206 related articles for article (PubMed ID: 19350634)
1. Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans.
Zhang YW; Eom SY; Kim YD; Song YJ; Yun HY; Park JS; Youn SJ; Kim BS; Kim H; Hein DW
Int J Cancer; 2009 Jul; 125(1):139-45. PubMed ID: 19350634
[TBL] [Abstract][Full Text] [Related]
2. N-Acetyltransferase 2 (NAT2) genetic variation and the susceptibility to noncardiac gastric adenocarcinoma in Taiwan.
Chang CH; Huang YS; Perng CL; Lin HC
J Chin Med Assoc; 2016 Mar; 79(3):105-10. PubMed ID: 26617241
[TBL] [Abstract][Full Text] [Related]
3. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M
BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288
[TBL] [Abstract][Full Text] [Related]
4. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
5. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907
[TBL] [Abstract][Full Text] [Related]
6. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
[TBL] [Abstract][Full Text] [Related]
8. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
Habil MR; Doll MA; Hein DW
Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247
[TBL] [Abstract][Full Text] [Related]
12. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
[TBL] [Abstract][Full Text] [Related]
14. Meat intake and bladder cancer in a prospective study: a role for heterocyclic aromatic amines?
Lumbreras B; Garte S; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen JP; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Hallmans G; Day NE; Key TJ; Saracci R; Kaaks R; Malaveille C; Ferrari P; Boffetta P; Norat T; Riboli E; Gonzalez CA; Vineis P
Cancer Causes Control; 2008 Aug; 19(6):649-56. PubMed ID: 18264785
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis.
Yu J; Deng Y; Chen JP
Tumour Biol; 2014 Jul; 35(7):6861-5. PubMed ID: 25051916
[TBL] [Abstract][Full Text] [Related]
16. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
17. NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis.
Zhong X; Hui C; Xiao-Ling W; Yan L; Na L
Arch Med Res; 2010 May; 41(4):275-80. PubMed ID: 20637371
[TBL] [Abstract][Full Text] [Related]
18. Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley.
Malik MA; Upadhyay R; Modi DR; Zargar SA; Mittal B
Arch Med Res; 2009 Jul; 40(5):416-23. PubMed ID: 19766908
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism in the N-acetyltransferase 2 gene in patients with lung cancer. Short communication].
Zabost A; Roszkowska-Śliż B; Wiatr E; Radzikowska E; Rogala E; Zych J; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K; Szczepulska-Wójcik E
Pneumonol Alergol Pol; 2012; 80(4):323-8. PubMed ID: 22714076
[TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
